Seek Returns logo

PHG vs. QGEN: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at PHG and QGEN, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

PHG trades as New York Registered Shares, providing U.S. investors with access to a foreign company, while QGEN is a standard domestic stock.

SymbolPHGQGEN
Company NameKoninklijke Philips N.V.Qiagen N.V.
CountryNetherlandsNetherlands
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesLife Sciences Tools & Services
Market Capitalization26.43 billion USD10.67 billion USD
ExchangeNYSENYSE
Listing DateMarch 17, 1980June 28, 1996
Security TypeNY Reg ShrsCommon Stock

Historical Performance

This chart compares the performance of PHG and QGEN by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

PHG vs. QGEN: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolPHGQGEN
5-Day Price Return1.54%0.49%
13-Week Price Return12.47%14.95%
26-Week Price Return-12.21%22.82%
52-Week Price Return-11.79%4.79%
Month-to-Date Return2.68%-0.28%
Year-to-Date Return-2.79%10.49%
10-Day Avg. Volume1.10M1.22M
3-Month Avg. Volume1.84M1.45M
3-Month Volatility28.64%21.16%
Beta1.050.68

Profitability

Return on Equity (TTM)

PHG

-0.18%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

PHG has a negative Return on Equity of -0.18%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

QGEN

10.66%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

QGEN’s Return on Equity of 10.66% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

PHG vs. QGEN: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

PHG

0.90%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Net Profit Margin of 0.90% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

QGEN

18.30%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 18.30% places QGEN in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

PHG vs. QGEN: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

PHG

6.11%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

PHG’s Operating Profit Margin of 6.11% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

QGEN

22.84%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 22.84% places QGEN in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

PHG vs. QGEN: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolPHGQGEN
Return on Equity (TTM)-0.18%10.66%
Return on Assets (TTM)-0.08%6.40%
Net Profit Margin (TTM)0.90%18.30%
Operating Profit Margin (TTM)6.11%22.84%
Gross Profit Margin (TTM)43.85%63.73%

Financial Strength

Current Ratio (MRQ)

PHG

1.26

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

PHG’s Current Ratio of 1.26 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

QGEN

1.61

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

QGEN’s Current Ratio of 1.61 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

PHG vs. QGEN: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

PHG

0.81

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

PHG’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.81. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

QGEN

0.41

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

QGEN’s Debt-to-Equity Ratio of 0.41 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

PHG vs. QGEN: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

PHG

1.41

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Interest Coverage Ratio of 1.41 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

QGEN

27.84

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

QGEN’s Interest Coverage Ratio of 27.84 is in the upper quartile for the Life Sciences Tools & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

PHG vs. QGEN: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolPHGQGEN
Current Ratio (MRQ)1.261.61
Quick Ratio (MRQ)0.811.19
Debt-to-Equity Ratio (MRQ)0.810.41
Interest Coverage Ratio (TTM)1.4127.84

Growth

Revenue Growth

PHG vs. QGEN: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

PHG vs. QGEN: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

PHG

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

PHG’s Dividend Yield of 0.00% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.

QGEN

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

QGEN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

PHG vs. QGEN: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

PHG

0.42%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

PHG’s Dividend Payout Ratio of 0.42% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

QGEN

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

QGEN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

PHG vs. QGEN: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolPHGQGEN
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.42%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

PHG

140.05

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

At 140.05, PHG’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Equipment & Supplies industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

QGEN

28.51

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

QGEN’s P/E Ratio of 28.51 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

PHG vs. QGEN: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

PHG

1.26

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s P/S Ratio of 1.26 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

QGEN

5.22

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

QGEN’s P/S Ratio of 5.22 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

PHG vs. QGEN: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

PHG

1.89

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

PHG’s P/B Ratio of 1.89 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

QGEN

2.97

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

QGEN’s P/B Ratio of 2.97 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

PHG vs. QGEN: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolPHGQGEN
Price-to-Earnings Ratio (TTM)140.0528.51
Price-to-Sales Ratio (TTM)1.265.22
Price-to-Book Ratio (MRQ)1.892.97
Price-to-Free Cash Flow Ratio (TTM)14.6621.47